Literature DB >> 14719767

Gallstone disease and its complications.

Jeffrey D Browning1, Jay D Horton.   

Abstract

Gallstone disease is one of the most common disorders of the gastrointestinal tract, and more cholecystectomies are performed each year in the United States than any other elective abdominal operation. As such, clinicians need a fundamental knowledge of gallstone disease and the common complications that are associated with this disease. Overall, the prevalence of gallstones in the United States is approximately 10% to 15%, of which, approximately 80% are without symptoms. Symptoms will occur in approximately 20% of those with gallstones, and this subgroup is at the highest risk for developing serious complications from their gallstone disease. These complications can range from simple recurrent biliary colic to severe, life-threatening ascending cholangitis and/or pancreatitis. This review will outline the basis for gallstone formation, the underlying mechanisms that result in gallstone-induced symptoms and a rational approach to individuals who present with symptoms consistent with gallstone disease. Current diagnostic and treatment modalities will be discussed, with a particular emphasis on acute cholecystitis and acute biliary pancreatitis.

Entities:  

Mesh:

Year:  2003        PMID: 14719767

Source DB:  PubMed          Journal:  Semin Gastrointest Dis        ISSN: 1049-5118


  13 in total

1.  Massive intraabdominal bleeding as a complication of acute cholangitis and portal vein thrombosis due to cholecystocholedocolithiasis.

Authors:  Wael I Al-Daraji; Richard J Prescott
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

2.  Non-invasive assessment of choledocholithiasis in patients with gallstones and abnormal liver function.

Authors:  Bilal O Al-Jiffry; Abdeen Elfateh; Tariq Chundrigar; Bassem Othman; Owaid Almalki; Fares Rayza; Hashem Niyaz; Hesham Elmakhzangy; Mohammed Hatem
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 3.  [Epidemiology and clinical presentation of acute cholecystitis].

Authors:  K Götzky; P Landwehr; J Jähne
Journal:  Chirurg       Date:  2013-03       Impact factor: 0.955

4.  Role of antibiotic therapy in mild acute calculus cholecystitis: a prospective randomized controlled trial.

Authors:  Haggi Mazeh; Ido Mizrahi; Uri Dior; Natalia Simanovsky; Mervyn Shapiro; Herbert R Freund; Ahmed Eid
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

Review 5.  [Cholecystectomy in acute cholecystitis-a surgical emergency or elective in the next day's program?]

Authors:  Carsten Gutt; Simon Schläfer
Journal:  Chirurgie (Heidelb)       Date:  2022-03-04

Review 6.  Porcelain gallbladder: a benign process or concern for malignancy?

Authors:  Thomas Schnelldorfer
Journal:  J Gastrointest Surg       Date:  2013-02-20       Impact factor: 3.452

7.  Understanding the reasons for the refusal of cholecystectomy in patients with cholelithiasis: how to help them in their decision?

Authors:  Adilson Peron; Ana Laura Schliemann; Fernando Antonio de Almeida
Journal:  Arq Bras Cir Dig       Date:  2014 Apr-Jun

8.  Acute cholecystitis - early laparoskopic surgery versus antibiotic therapy and delayed elective cholecystectomy: ACDC-study.

Authors:  Kilian Weigand; Jörg Köninger; Jens Encke; Markus W Büchler; Wolfgang Stremmel; Carsten N Gutt
Journal:  Trials       Date:  2007-10-04       Impact factor: 2.279

9.  Significantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based cohort study.

Authors:  Muideen Tunbosun Olaiya; Hung-Yi Chiou; Jiann-Shing Jeng; Li-Ming Lien; Fang-I Hsieh
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

10.  The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.

Authors:  Qian Zhu; Xiubin Sun; Xiaokang Ji; Lin Zhu; Jing Xu; Chunxia Wang; Chengqi Zhang; Fuzhong Xue; Yanxun Liu
Journal:  Sci Rep       Date:  2016-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.